Iradimed Corp. (IRMD) Tops Q2 EPS by 5c, Offers Guidance
Get Alerts IRMD Hot Sheet
Join SI Premium – FREE
Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.14, $0.05 better than the analyst estimate of $0.09. Revenue for the quarter came in at $9.8 million versus the consensus estimate of $8.46 million.
GUIDANCE:
Iradimed Corp. sees Q3 2021 EPS of $0.16-$0.17, versus the consensus of $0.13. Iradimed Corp. sees Q3 2021 revenue of $10.3-10.5 million, versus the consensus of $9.4 million.
Iradimed Corp. sees FY2021 EPS of $0.60-$0.62, versus the consensus of $0.53. Iradimed Corp. sees FY2021 revenue of $40-40.4 million, versus the consensus of $37.5 million.
For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbus revenue rises, delivers 142 commercial aircraft in Q1
- PHINIA Inc. (PHIN) Reports Q1 EPS of $1.08, provides guidance
- Ladder Capital (LADR) Tops Q1 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!